Impact of Intensive Outpatient Rehabilitation on Non-Motor Patient-Reported Outcomes in Parkinson's Disease (INTENSO)
INTENSO
1 other identifier
observational
48
1 country
1
Brief Summary
This historical cohort study aims to evaluate the impact of different intensity rehabilitation protocols on the short and medium-term severity of non-motor symptoms in patients with Parkinson's Disease. One of the principal strengths of this study is that it is a real-life study, so it has a high external validity necessary to test the clinical effectiveness of these two types of training, which could have significant practical implications for rehabilitation in Parkinson's disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2024
CompletedFirst Submitted
Initial submission to the registry
November 9, 2024
CompletedFirst Posted
Study publicly available on registry
November 19, 2024
CompletedNovember 19, 2024
November 1, 2024
6 years
November 9, 2024
November 16, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Changes in Non-motor Symptoms
The changes in non-motor symptoms mesaured by the Non Motor Symptoms Scale ( NMSS; score range: 0-360; higher scores mean a worse outcome)
before treatment, immediately after treatment, and six months following the end of the treatment
Changes in Non-motor Symptoms
The changes in non-motor symptoms mesaured by the Unified Parkinson's Disease Rating Scale part I ( UPDRS part I; score range 0-52; higher scores mean a worse outcome)
before treatment, immediately after treatment, and six months following the end of the treatment
Secondary Outcomes (3)
Changes in Parkinson's Disease related disability
before treatment, immediately after treatment, and six months following the end of the treatment
Changes in motor symptoms severity
before treatment, immediately after treatment, and six months following the end of the treatment
Changes in the severity of the Freezing of Gait
before treatment, immediately after treatment, and six months following the end of the treatment
Study Arms (1)
People with Parkinson's Disease consecutively referred to the outpatient rehabilitation facility
Single center historical cohort study of people with PD consecutively referred to the outpatient rehabilitation facility of a Center for Diagnosis and Treatment of Movement Disorders, based in a university hospital in Italy.
Interventions
In High Intensive Training patients received 1800 minutes of training globally. In our practice, a single outpatient session varies from 60 to 90 minutes, the number of sessions per cycle from 10 to 20, and the frequency from 2 days a week to 5 days a week. Irrespective of total course intensity, each session comprises at least 15 minutes of aerobic training (over ground or treadmill) and 10 minutes of flexibility and strengthening exercise. No less than 10 minutes of balance training, 10 minutes of overground training in dual tasks, and 15 minutes of occupational therapy are additionally delivered. The duration of the single training components in each session may increase according to the patients' functioning profiles, requesting a more intensive practice of gait, balance or trunk alignment or a focused training of arm dexterity or basic ADL.
In Low Intensive Training patients received less than 900 minutes of training globally. In our practice, a single outpatient session varies from 60 to 90 minutes, the number of sessions per cycle from 10 to 20, and the frequency from 2 days a week to 5 days a week. Irrespective of total course intensity, each session comprises at least 15 minutes of aerobic training (over ground or treadmill) and 10 minutes of flexibility and strengthening exercise. No less than 10 minutes of balance training, 10 minutes of overground training in dual tasks, and 15 minutes of occupational therapy are additionally delivered. The duration of the single training components in each session may increase according to the patients' functioning profiles, requesting a more intensive practice of gait, balance or trunk alignment or a focused training of arm dexterity or basic ADL.
Eligibility Criteria
The study population is characterized by people with Parkinson's Disease consecutively referred to the outpatient rehabilitation facility of a Center for Diagnosis and Treatment of Movement Disorders, based in a university hospital in Italy.
You may qualify if:
- adults diagnosed with Idiopathic PD, Hoehn \& Yahr stage ≥ 1 \< 5, consecutive referral to the rehabilitation facility between 1 January 2014 and 31 December 2019 to receive outpatient physiotherapy treatment for the management of motor disability, specifically targeting gait, balance, or posture disorders;
- completion of the course of rehabilitation treatment;
- availability of Non-Motor Symptom Scale and Unified Parkinson's Disease Rating Scale, recorded before and after treatment and 6 plus or minus 1 months later
You may not qualify if:
- diagnosis of any primary or secondary parkinsonism rather than PD
- symptom onset since less than three years
- any concomitant neurological disease (e.g. polyneuropathy, stroke, etc)
- any other chronically disabling disease (e.g. severe heart, liver or kidney failure, cancer, psychiatric disorders, limb amputation, severe musculoskeletal or neuropathic pain)
- changes in antiparkinsonian drug therapy during the whole study period
- exposure to a course of physiotherapy during the 6 months preceding the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Experimental and Clinical Medicine, Politecnica delle Marche University,
Ancona, AN, 60126, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marianna Capecci, MD
Università Politecnica delle Marche
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
November 9, 2024
First Posted
November 19, 2024
Study Start
January 1, 2014
Primary Completion
December 31, 2019
Study Completion
August 1, 2024
Last Updated
November 19, 2024
Record last verified: 2024-11